FMS Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)
NYSE · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 二月 24, 2026
$22.25
· % 处于52周区间
· 高于低点
· 至高点
$20.0252周低点
$27.6452周高点
P/E
7.1
EPS
$3.36
收入
$19.63B
FMS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$22.25
P/E
7.1
EPS
$3.36
收入
$19.63B
ROE
7.0%
52周区间
$20–$28
FMS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2012年12月4日 | 2-for-1 | 正向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$19.63B2016-12-31 → 2025-12-31
EPS$3.362016-12-31 → 2025-12-31
自由现金流·2016-12-31 → 2019-12-31
净利率5.0%2017-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | FMS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | 7.15年均值 ≈9.7 | ≈9.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | FMS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Operating Margin (营业利润率) | 9.3%5年均值 ≈8.4% | ≈8.4% | · | · | |
| EBITDA Margin (息税折旧摊销前利润率) | 16.8%5年均值 ≈16.7% | ≈16.7% | · | · | |
| Pretax Margin (税前利润率) | 7.7%5年均值 ≈6.7% | ≈6.7% | · | · | |
| Net Profit Margin (净利润率) | 5.0%5年均值 ≈3.9% | ≈3.9% | · | · | |
| ROA | 3.0%5年均值 ≈2.2% | ≈2.2% | · | · | |
| ROE | 7.0%5年均值 ≈5.5% | ≈5.5% | · | · | |
| ROIC | 10.8%5年均值 ≈8.8% | ≈8.8% | · | · |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | FMS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 1.35年均值 ≈1.3 | ≈1.3 | · | · | |
| Quick Ratio (速动比率) | 0.15年均值 ≈0.1 | ≈0.1 | · | · | |
| Interest Coverage (利息保障倍数) | 4.95年均值 ≈4.3 | ≈4.3 | · | · |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | FMS | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.65年均值 ≈0.6 | ≈0.6 | · | · | |
| Inventory Turnover (库存周转率) | 6.95年均值 ≈6.6 | ≈6.6 | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$183.0K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
股息 收益率、派息率、股息历史、5年CAGR
年度化派息≈$0.87
5年股息复合年增长率 (CAGR)≈2.9%
增长连胜≈2
| 除息日 | 金额 | 货币 | 收益率 |
|---|---|---|---|
| 五月 22, 2026 | $0.87 | USD | ≈4.0% |
| 五月 23, 2025 | $0.82 | USD | ≈2.8% |
| 五月 17, 2024 | $0.63 | USD | ≈2.9% |
| 五月 17, 2023 | $0.62 | USD | ≈2.7% |
| 五月 13, 2022 | $0.71 | USD | ≈2.4% |
| 五月 24, 2021 | $0.83 | USD | ≈2.1% |
| 八月 28, 2020 | $0.71 | USD | ≈1.7% |
| 五月 17, 2019 | $0.66 | USD | ≈1.7% |
| 五月 21, 2018 | $0.63 | USD | ≈1.2% |
| 五月 11, 2017 | $0.51 | USD | ≈1.1% |
| 五月 10, 2016 | $0.44 | USD | ≈1.0% |
| 五月 15, 2015 | $0.44 | USD | ≈1.0% |
| 五月 13, 2014 | $0.53 | USD | ≈1.6% |
| 五月 14, 2013 | $0.49 | USD | ≈1.4% |
| 五月 8, 2012 | $0.46 | USD | ≈1.3% |
| 五月 10, 2011 | $0.48 | USD | ≈1.3% |
| 五月 7, 2010 | $0.41 | USD | ≈1.7% |
| 五月 5, 2009 | $0.37 | USD | ≈2.0% |
| 五月 16, 2008 | $0.42 | USD | ≈1.5% |
| 五月 11, 2007 | $0.31 | USD | ≈1.2% |
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
16.5%
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | $1.13 | $1.05 | 7.2% | |
| 2026年3月31日 | $0.91 | $0.99 | -8.3% | |
| 2025年12月31日 | $1.44 | $1.06 | 35.6% | |
| 2025年9月30日 | $1.10 | $0.96 | 14.2% | |
| 2025年6月30日 | $0.91 | $0.79 | 14.9% | |
| 2025年3月31日 | $1.44 | $1.06 | 35.6% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.63B | $19.34B | $19.45B | $19.40B | $17.62B | $17.86B | $17.48B | $16.55B | $17.78B | $16.57B | $15.45B | $5.27B | |
| Cost of Revenue | $14.60B | $14.58B | $14.53B | $14.50B | $12.85B | $12.32B | $12.08B | $11.39B | $11.77B | $10.95B | $10.28B | $10.84B | |
| Gross Profit | · | · | · | $5.31B | $5.08B | $5.54B | $5.40B | $5.15B | $6.02B | $5.62B | $5.18B | $5.00B | |
| R&D Expense | $158M | $183M | $232M | $229M | $221M | $194M | $168M | $114M | $111M | $147M | $128M | $122M | |
| SG&A Expense | $3.03B | $3.14B | $3.20B | $3.17B | $2.77B | $3.13B | $3.03B | $2.89B | $3.64B | $3.13B | $2.95B | $2.64B | |
| Operating Income | $1.83B | $1.39B | $1.37B | $1.51B | $1.85B | $2.30B | $2.27B | $3.04B | $2.36B | $2.41B | $2.13B | $2.25B | |
| Interest Expense | $375M | $393M | $421M | $359M | $344M | $407M | $486M | $438M | $-365M | $-363M | $458M | $495M | |
| Interest Income | $70M | $72M | $88M | $68M | $73M | $42M | $62M | $147M | $51M | $-63M | $105M | $84M | |
| Pretax Income | $1.51B | $1.06B | $1.03B | $1.22B | $1.57B | $1.94B | $1.84B | $2.74B | $2.00B | $2.05B | $1.78B | $1.84B | |
| Income Tax | $321M | $316M | $301M | $325M | $353M | $501M | $402M | $511M | $443M | $625M | $565M | $584M | |
| Net Income | $978M | $538M | $499M | $673M | $969M | $1.16B | $1.20B | $1.98B | $1.28B | $1.14B | $955M | $1.05B | |
| EPS (Basic) | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 | $3.96 | $3.96 | $6.47 | $4.17 | $3.74 | $3.14 | $3.46 | |
| EPS (Diluted) | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 | $3.96 | $3.96 | $6.45 | $4.16 | $3.73 | $3.13 | $3.45 | |
| Shares (Basic) | 291,190,575 | 293,413,449 | 293,413,449 | 293,246,430 | 292,944,732 | 294,055,525 | 302,691,397 | 306,541,706 | 306,563,400 | 305,748,381,000 | 304,440,184 | 302,339,124 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | 306,257,744 | 304,920,035 | 302,867,896 | |
| EBITDA | $3.29B | $2.93B | $2.98B | $3.23B | $3.44B | $3.89B | $3.82B | $2.31B | $2.36B | $3.41B | $3.04B | $2.95B |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $930M | $837M | $1.08B | $911M | $925M | $747M | $769M | $832M | $620M | $533M | $550M | $634M | |
| Receivables | · | · | · | · | · | · | $3.42B | $3.23B | · | · | $3.29B | $3.20B | |
| Inventory | $2.14B | $2.07B | $2.18B | $2.30B | $2.04B | $1.90B | $1.66B | $1.47B | $1.29B | $1.34B | $1.34B | $1.12B | |
| Prepaid Expense | · | · | · | · | · | · | · | · | · | · | $1.37B | $1.33B | |
| Current Assets | $7.90B | $7.92B | $8.70B | $8.20B | $7.97B | $7.28B | $7.17B | $7.85B | $6.37B | $6.88B | $6.77B | $6.72B | |
| PP&E (Net) | $3.49B | $3.65B | $3.78B | $4.15B | $4.24B | $4.06B | $4.19B | $3.84B | $3.49B | $3.58B | $3.43B | $3.29B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | $7.41B | $7.04B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $3.98B | $3.75B | |
| Goodwill | $13.57B | $15.17B | $14.65B | $15.79B | $14.36B | $12.96B | $14.02B | $12.21B | $12.10B | $12.96B | $13.03B | $13.08B | |
| Intangibles | $1.25B | $1.37B | $1.36B | $1.52B | $1.46B | $1.38B | $1.43B | $681M | $683M | $803M | $830M | $869M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $474M | $603M | |
| Total Assets | $31.00B | $33.57B | $33.93B | $35.75B | $34.37B | $31.69B | $32.93B | $26.24B | $24.03B | $25.50B | $25.37B | $25.38B | |
| Accounts Payable | · | · | · | · | · | · | $717M | $641M | $590M | $576M | $628M | $573M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | $2.50B | $2.20B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $109M | $133M | |
| Current Liabilities | $6.25B | $5.66B | $6.11B | $6.47B | $7.26B | $6.06B | $7.06B | $6.27B | $5.30B | $5.30B | $4.15B | $3.48B | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $624M | $805M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $466M | $412M | |
| Total Liabilities | $16.72B | $17.80B | $19.10B | $20.30B | $20.39B | $19.36B | $19.71B | $13.34B | $13.20B | $14.45B | $13.84B | $14.53B | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | $387M | $385M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | $3.47B | $3.55B | |
| Retained Earnings | $12.21B | $11.27B | $10.92B | $10.71B | $10.83B | $10.25B | $9.45B | $8.83B | $7.14B | $6.09B | $7.87B | $7.10B | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $-1.34B | $-1.09B | |
| Stockholders' Equity | $13.31B | $14.58B | $13.62B | $13.99B | $12.70B | $11.22B | $11.96B | $11.76B | $9.82B | $9.98B | $9.89B | $9.44B | |
| Liabilities + Equity | · | · | · | · | · | · | · | · | · | · | $25.37B | $25.38B |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.46B | $1.54B | $1.61B | $1.72B | $1.59B | $1.59B | $1.55B | $725M | $735M | $-702M | $717M | $699M | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | $26M | $7M | $6M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $-18M | $-47M | $99M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | $118M | $110M | $98M | |
| Other Non-cash | $239M | $313M | $517M | $-225M | $-65M | $1.48B | $-186M | $805M | · | $113M | $254M | $18M | |
| Operating Cash Flow | $2.68B | $2.39B | $2.63B | $2.17B | $2.49B | $4.23B | $2.57B | $2.06B | $2.19B | $1.93B | $1.77B | $1.86B | |
| CapEx | · | · | · | · | · | · | $1.12B | $1.06B | $944M | $-931M | $859M | $932M | |
| Investing Cash Flow | $-723M | $-85M | $-544M | $-735M | $-1.20B | $-1.33B | $-3.29B | $-245M | $-992M | $-1.25B | $-902M | $-2.69B | |
| Dividends Paid | · | · | · | · | · | · | $355M | $325M | $294M | $-244M | $237M | $-318M | |
| Financing Cash Flow | $-1.40B | $-2.57B | $-1.86B | $-1.62B | $-1.02B | $-2.66B | $-467M | $-682M | $-799M | $-520M | $-907M | $805M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | $198M | $-84M | $-49M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | $599M | $547M | $690M | |
| Free Cash Flow | · | · | · | · | · | · | $1.44B | $3.12B | $1.25B | $1.11B | $1.01B | $930M | |
| Levered FCF | · | · | · | · | · | · | $1.06B | $3.36B | $940M | $796M | $662M | $591M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 27.4% | 28.8% | 31.0% | 30.9% | 31.1% | 33.8% | · | · | 94.9% | |
| Operating Margin | 9.3% | 7.2% | 7.0% | 7.8% | 10.5% | 12.9% | 13.0% | 18.4% | 13.3% | · | · | 42.8% | |
| Net Margin | 5.0% | 2.8% | 2.6% | 3.5% | 5.5% | 6.5% | 6.9% | 12.0% | 7.2% | · | · | 19.9% | |
| Pretax Margin | 7.7% | 5.5% | 5.3% | 6.3% | 8.9% | 10.8% | 10.5% | 16.5% | 11.3% | · | · | 35.0% | |
| EBITDA Margin | 16.8% | 15.1% | 15.3% | 16.7% | 19.5% | 21.8% | 21.9% | 14.0% | 13.3% | · | · | 56.1% | |
| ROA | 3.0% | 1.6% | 1.4% | 1.9% | 2.9% | 3.6% | 4.0% | · | 5.2% | · | · | · | |
| ROE | 7.0% | 3.8% | 3.6% | 5.1% | 8.1% | 10.1% | 10.1% | · | 12.9% | · | · | · | |
| ROIC | 10.8% | 6.7% | 7.1% | 7.9% | 11.3% | 15.2% | 14.8% | · | 18.6% | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | 1.4 | 1.3 | 1.1 | 1.2 | 1.0 | · | 1.2 | · | · | · | |
| Quick Ratio | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.6 | · | 0.1 | · | · | · | |
| Interest Coverage | 4.9 | 3.5 | 3.3 | 4.2 | 5.4 | 5.7 | 4.7 | -10.1 | 5.9 | 5.8 | 4.6 | 4.6 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | · | 0.7 | · | · | · | |
| Inventory Turnover | 6.9 | 6.9 | 6.5 | 6.5 | 6.4 | 6.9 | 7.7 | · | 9.0 | · | · | · | |
| Receivables Turnover | · | · | · | · | · | · | 5.3 | · | · | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | $17.39 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $6.99 | $6.43 | $6.15 | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | $0.80 | $0.78 | $0.77 | |
| EPS (TTM) | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 | $3.96 | $3.96 | $6.45 | $4.16 | $3.73 | $3.13 | $3.45 |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19.63B | $19.34B | $19.45B | $19.40B | $17.62B | $17.86B | $17.48B | $16.55B | $17.78B | $16.57B | $15.45B | $5.27B | |
| Net Income TTM | $978M | $538M | $499M | $673M | $969M | $1.16B | $1.20B | $1.98B | $1.28B | $1.14B | $955M | $1.05B | |
| P/E | 7.1 | 12.4 | 12.3 | 7.1 | 9.8 | 10.5 | 9.3 | 5.0 | 12.6 | 11.3 | 13.4 | 10.8 | |
| Earnings Yield | 14.1% | 8.1% | 8.2% | 14.1% | 10.2% | 9.5% | 10.8% | 19.9% | 7.9% | 8.8% | 7.5% | 9.3% | |
| Payout Ratio | · | · | · | · | · | · | 29.6% | -16.4% | 23.0% | -22.3% | -25.6% | 30.4% | |
| Annual Payout | · | · | · | · | · | · | $355M | $325M | $294M | $-244M | $237M | $-318M |
资产负债表
| 指标 | 趋势 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2011 | Q4 2010 | Q4 2008 | Q4 2007 | Q4 2006 | Q4 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $832M | $747M | $550M | $634M | · | · | · | · | · | · | |
| Receivables | · | $3.52B | $3.29B | $3.20B | · | · | · | · | · | · | |
| Inventory | $1.47B | $1.41B | $1.34B | $1.12B | · | · | · | · | · | · | |
| Prepaid Expense | · | $1.41B | $1.37B | $1.33B | · | · | · | · | · | · | |
| Current Assets | $7.85B | $7.31B | $6.98B | $6.72B | · | · | · | · | · | · | |
| PP&E (Net) | $3.84B | $3.77B | $3.43B | $3.29B | · | · | · | · | · | · | |
| PP&E (Gross) | · | $8.16B | $7.41B | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | $4.39B | $3.98B | $-3.75B | · | · | · | · | · | · | |
| Goodwill | $12.21B | $13.67B | $13.03B | $13.08B | · | · | · | · | · | · | |
| Intangibles | $681M | $847M | $830M | $869M | · | · | · | · | · | · | |
| Other Non-current Assets | · | $451M | $474M | $663M | · | · | · | · | · | · | |
| Total Assets | $26.24B | $26.93B | $25.53B | $25.45B | · | · | · | · | · | · | |
| Accounts Payable | $641M | $607M | $628M | $573M | · | · | · | · | · | · | |
| Accrued Liabilities | · | $2.65B | $2.50B | $2.20B | · | · | · | · | · | · | |
| Short-term Debt | · | $602M | $109M | $133M | · | · | · | · | · | · | |
| Current Liabilities | $6.27B | $5.04B | $4.19B | $3.48B | · | · | · | · | · | · | |
| Deferred Tax | · | $672M | $756M | $805M | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | $659M | $466M | $412M | · | · | · | · | · | · | |
| Total Liabilities | $13.34B | $14.24B | $14.01B | $14.59B | · | · | · | · | · | · | |
| Common Stock | · | $380M | $387M | $385M | · | · | · | · | · | · | |
| Paid-in Capital | · | $2.98B | $3.47B | $3.55B | · | · | · | · | · | · | |
| Retained Earnings | $8.83B | $8.84B | $7.87B | $7.10B | · | · | · | · | · | · | |
| AOCI | · | $-1.32B | $-1.34B | $-1.09B | · | · | · | · | · | · | |
| Stockholders' Equity | $11.76B | $10.81B | $9.89B | $9.44B | · | · | · | · | · | · | |
| Liabilities + Equity | · | $26.93B | $25.53B | $25.45B | · | · | · | · | · | · | |
| Shares Outstanding | · | 306,221,840 | 305,314,120 | 301,446,779 | · | · | · | · | · | · |
每股
| 指标 | 趋势 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2011 | Q4 2010 | Q4 2008 | Q4 2007 | Q4 2006 | Q4 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | $6.45 | · | · | · | $3.51 | $3.24 | $2.74 | $2.42 | · | · |
估值 (TTM)
| 指标 | 趋势 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2011 | Q4 2010 | Q4 2008 | Q4 2007 | Q4 2006 | Q4 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16.55B | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $1.98B | · | · | · | $1.07B | $979M | $818M | $717M | · | · | |
| P/E | 5.0 | · | · | · | 9.7 | 8.9 | 8.6 | 10.9 | · | · | |
| Earnings Yield | 19.9% | · | · | · | 10.3% | 11.2% | 11.6% | 9.2% | · | · | |
| Annual Payout | $325M | · | · | · | $281M | $232M | $252M | $188M | · | · |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $19.63B | $19.34B | $19.45B | $19.40B | $17.62B |
| 毛利率 % | · | · | · | 27.4% | 28.8% |
| 营业利润率 % | 9.3% | 7.2% | 7.0% | 7.8% | 10.5% |
| 净收入 | $978M | $538M | $499M | $673M | $969M |
| 稀释后每股收益 (EPS) | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 1.3 | 1.4 | 1.4 | 1.3 | 1.1 |
| 速动比率 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 |
此报表无数据
基本面数据不足，尚无法生成此报表。
机构持有人 (13F) 252 家申报者 · $943.5M 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
252
持有价值
$943.5M
新仓位
47
已退出持仓
27
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 47 (0 与上一季度对比) | 27 (-7 与上一季度对比) | 101 (+12 与上一季度对比) | 44 (-1 与上一季度对比) | +363K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| PZENA INVESTMENT MANAGEMENT LLC | $338970952 | 14992081 | 35.93% | 股份 |
| MORGAN STANLEY | $98302636 | 4347748 | 10.42% | 股份 |
| Dodge & Cox | $86526435 | 3826910 | 9.17% | 股份 |
| FIDUCIARY MANAGEMENT INC /WI/ | $66424314 | 2937829 | 7.04% | 股份 |
| BRANDES INVESTMENT PARTNERS, LP | $43323176 | 1916090 | 4.59% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $35538511 | 1571805 | 3.77% | 股份 |
| TODD ASSET MANAGEMENT LLC | $29514940 | 1305386 | 3.13% | 股份 |
| GOLDMAN SACHS GROUP INC | $20318888 | 898668 | 2.15% | 股份 |
| BlackRock, Inc. | $19451429 | 860302 | 2.06% | 股份 |
| Quantinno Capital Management LP | $11937327 | 527966 | 1.27% | 股份 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $10526922 | 465587 | 1.12% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $9692471 | 428696 | 1.03% | 股份 |
| NORTHERN TRUST CORP | $8703946 | 384960 | 0.92% | 股份 |
| WELLS FARGO & COMPANY/MN | $8622583 | 381361 | 0.91% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $8247454 | 364770 | 0.87% | 股份 |
| Moran Wealth Management, LLC | $8188845 | 362178 | 0.87% | 股份 |
| Creative Planning | $6722694 | 297333 | 0.71% | 股份 |
| ROYAL BANK OF CANADA | $5942000 | 262797 | 0.63% | 股份 |
| FMR LLC | $5554864 | 245682 | 0.59% | 股份 |
| ABC ARBITRAGE SA | $5420770 | 239751 | 0.57% | 股份 |
| JPMORGAN CHASE & CO | $5043147 | 222165 | 0.53% | 股份 |
| UBS Group AG | $4968502 | 219748 | 0.53% | 股份 |
| D. E. Shaw & Co., Inc. | $4764990 | 210747 | 0.51% | 股份 |
| ASSETMARK, INC | $4127878 | 182569 | 0.44% | 股份 |
| Trexquant Investment LP | $4067245 | 179887 | 0.43% | 股份 |
| Cinctive Capital Management LP | $3776232 | 167016 | 0.40% | 股份 |
| NIA IMPACT ADVISORS, LLC | $3092356 | 136769 | 0.33% | 股份 |
| RITHOLTZ WEALTH MANAGEMENT | $2903193 | 128403 | 0.31% | 股份 |
| JANE STREET GROUP, LLC | $2303462 | 101878 | 0.24% | 股份 |
| STIFEL FINANCIAL CORP | $2152041 | 95180 | 0.23% | 股份 |
| Cubist Systematic Strategies, LLC | $2094762 | 79558 | 0.22% | 股份 |
| QRG CAPITAL MANAGEMENT, INC. | $2018326 | 89267 | 0.21% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $2015048 | 89122 | 0.21% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $1915142 | 84703 | 0.20% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1891191 | 83644 | 0.20% | 股份 |
| NATIONAL BANK OF CANADA /FI/ | $1855101 | 82048 | 0.20% | 股份 |
| SEARLE & CO. | $1825192 | 80725 | 0.19% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1770363 | 78300 | 0.19% | 卖出期权 |
| Point72 Asset Management, L.P. | $1737104 | 76829 | 0.18% | 股份 |
| DIVERSIFIED MANAGEMENT INC | $1647940 | 73047 | 0.17% | 股份 |
| SEI INVESTMENTS CO | $1605420 | 71001 | 0.17% | 股份 |
| Pathstone Holdings, LLC | $1574508 | 69638 | 0.17% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1512541 | 66897 | 0.16% | 股份 |
| XTX Topco Ltd | $1493911 | 66073 | 0.16% | 股份 |
| BANK OF MONTREAL /CAN/ | $1410140 | 62368 | 0.15% | 股份 |
| BANK OF AMERICA CORP /DE/ | $1345691 | 59517 | 0.14% | 股份 |
| BAROMETER CAPITAL MANAGEMENT INC. | $1315902 | 58200 | 0.14% | 股份 |
| Crossmark Global Holdings, Inc. | $1308961 | 57893 | 0.14% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $1303987 | 57673 | 0.14% | 股份 |
| MML INVESTORS SERVICES, LLC | $1297015 | 57365 | 0.14% | 股份 |
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Fresenius SE & Co. KGaA ×10 申报 | 2026年8月24日 | 25.60% | 修订 | 被动投资 | SEC |
| Fresenius Medical Care Holdings, Inc., Fresenius Medical Care AG | 2026年1月9日 | 9.50% | 修订 | · | SEC |
| Fresenius Medical Care AG | 2025年10月16日 | 9.90% | 修订 | · | SEC |
| Fresenius SE | 2008年7月29日 | · | 初始申报 | 并购/出售 | SEC |
| 未披露的报告人 | 2006年4月5日 | · | 初始申报 | 董事会活动 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 4 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
FMS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 29 位分析师
持有
中位数目标
$23.98
+7.8%
3 10.3%
强烈买入
3 10.3%
买入
11 37.9%
持有
10 34.5%
卖出
2 6.9%
强烈卖出
12个月价格目标
7 位分析师 · 2026-09-30平均目标 $23.76 +6.8%
现在
当前价格 $22.25
最低$17.05
平均值$23.76
最高$37.51
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 20-F 于 二月 24, 2026 申报